These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND B2M, P61769, 567, ENSG00000166710 AND Prognosis
26 results:

  • 1. CAF-associated genes putatively representing distinct prognosis by in silico landscape of stromal components of colon cancer.
    Okuno K; Ikemura K; Okamoto R; Oki K; Watanabe A; Kuroda Y; Kidachi M; Fujino S; Nie Y; Higuchi T; Chuman M; Washio M; Sakuraya M; Niihara M; Kumagai K; Sangai T; Kumamoto Y; Naitoh T; Hiki N; Yamashita K
    PLoS One; 2024; 19(4):e0299827. PubMed ID: 38557819
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Association between polyunsaturated fatty acids in adipose tissue and mortality of colorectal cancer patients.
    Roux-Levy C; Binquet C; Vaysse C; Scherrer ML; Ayav A; Ortega-Deballon P; Lakkis Z; Liu D; Deguelte S; Cottet V
    Nutrition; 2024 May; 121():112358. PubMed ID: 38401197
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Dentate line invasion as a predictive factor of poor distant relapse-free survival in locally advanced lower rectal cancer with anal sphincter involvement.
    Song M; Wang H; Wang L; Li S; Zhang Y; Geng J; Zhu X; Li Y; Cai Y; Wang W
    BMC Cancer; 2022 Nov; 22(1):1196. PubMed ID: 36403007
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic Value of Preoperative Serological Biomarkers in Patients Undergoing Curative-Intent Cytoreductive Surgery for colorectal cancer Peritoneal Metastases.
    El Asmar A; Delcourt M; Kamden L; Khaled C; Bohlok A; Moreau M; Sclafani F; Donckier V; Liberale G
    Ann Surg Oncol; 2023 Mar; 30(3):1863-1869. PubMed ID: 36350459
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Comparison of follow-up treatment regimens for colorectal cancer liver metastases without objective response to neoadjuvant chemotherapy: direct surgery or surgery after second-line chemotherapy].
    Lyu XY; Bi XY; Zhao H; Chen QC; Luo ZW; Zhang BL; Zhang XS; Cai JQ
    Zhonghua Wai Ke Za Zhi; 2022 May; 60(5):454-460. PubMed ID: 35359087
    [No Abstract]    [Full Text] [Related]  

  • 6. Treatment strategy for resectable colorectal cancer liver metastases from the viewpoint of time to surgical failure.
    Hirokawa F; Ueno M; Nakai T; Kaibori M; Nomi T; Iida H; Tanaka S; Komeda K; Hayami S; Kosaka H; Hokuto D; Kubo S; Uchiyama K
    Langenbecks Arch Surg; 2022 Mar; 407(2):699-706. PubMed ID: 34741671
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Association of Adiponectin and Vitamin D With Tumor Infiltrating Lymphocytes and Survival in Stage III Colon cancer.
    Sinicrope FA; Shi Q; Smyrk TC; Goldberg RM; Cohen SJ; Gill S; Kahlenberg MS; Nair S; Shield AF; Jahagirdar BN; Jacobson SB; Foster NR; Pollak MN; Alberts SR
    JNCI Cancer Spectr; 2021 Oct; 5(5):. PubMed ID: 34485815
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Oncological outcomes according to the treatment modality based on the size of rectal neuroendocrine tumors: a single-center retrospective study.
    Son J; Park IJ; Yang DH; Kim J; Kim KJ; Byeon JS; Hong SM; Kim YI; Kim JB; Lim SB; Yu CS; Kim JC
    Surg Endosc; 2022 Apr; 36(4):2445-2455. PubMed ID: 34009477
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosis.
    Chen SH; Miles K; Taylor SA; Ganeshan B; Rodriquez M; Fraioli F; Wan S; Afaq A; Shortman R; Walls D; Hoy L; Endozo R; Bhargava A; Hanson M; Huang J; Raouf S; Francis D; Siddiqi S; Arulampalam T; Sizer B; Machesney M; Reay-Jones N; Dindyal S; Ng T; Groves AM
    Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):371-384. PubMed ID: 33837843
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic and diagnostic value of circRNA expression in colorectal carcinoma: a meta-analysis.
    Yuan J; Guo D; Li X; Chen J
    BMC Cancer; 2020 May; 20(1):448. PubMed ID: 32429931
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy.
    Hamfjord J; Guren TK; Dajani O; Johansen JS; Glimelius B; Sorbye H; Pfeiffer P; Lingjærde OC; Tveit KM; Kure EH; Pallisgaard N; Spindler KG
    Ann Oncol; 2019 Jul; 30(7):1088-1095. PubMed ID: 31046124
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Impact of primary tumour location and RAS/BRAF mutational status in metastatic colorectal cancer treated with first-line regimens containing oxaliplatin and bevacizumab: Prognostic factors from the AIO KRK0207 first-line and maintenance therapy trial.
    Hegewisch-Becker S; Nöpel-Dünnebacke S; Hinke A; Graeven U; Reinacher-Schick A; Hertel J; Lerchenmüller CA; Killing B; Depenbusch R; Al-Batran SE; Lange T; Dietrich G; Tannapfel A; Arnold D
    Eur J Cancer; 2018 Sep; 101():105-113. PubMed ID: 30036739
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Somatic mutations of the coding microsatellites within the beta-2-microglobulin gene in mismatch repair-deficient colorectal cancers and adenomas.
    Clendenning M; Huang A; Jayasekara H; Lorans M; Preston S; O'Callaghan N; Pope BJ; Macrae FA; Winship IM; Milne RL; Giles GG; English DR; Hopper JL; Win AK; Jenkins MA; Southey MC; Rosty C; Buchanan DD;
    Fam Cancer; 2018 Jan; 17(1):91-100. PubMed ID: 28616688
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Do inflammatory markers predict prognosis in patients with synchronous colorectal cancer?
    He W; Wei M; Yang X; Chen B; Wu Q; Zheng E; Deng X; Wang Z
    Medicine (Baltimore); 2017 Apr; 96(17):e6607. PubMed ID: 28445257
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The Characteristics and Prognostic Effect of E-Cadherin Expression in colorectal Signet Ring Cell Carcinoma.
    Wang R; Ma X; Li Y; He Y; Huang D; Cai S; Peng J
    PLoS One; 2016; 11(8):e0160527. PubMed ID: 27509205
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Semaphorin 4D and hypoxia-inducible factor-1α overexpression is related to prognosis in colorectal carcinoma.
    Wang JS; Jing CQ; Shan KS; Chen YZ; Guo XB; Cao ZX; Mu LJ; Peng LP; Zhou ML; Li LP
    World J Gastroenterol; 2015 Feb; 21(7):2191-8. PubMed ID: 25717256
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Multiple regression analysis of mRNA-miRNA associations in colorectal cancer pathway.
    Wang F; Wong SC; Chan LW; Cho WC; Yip SP; Yung BY
    Biomed Res Int; 2014; 2014():676724. PubMed ID: 24895601
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Correlation and clinical significance of expressions of HIF-1α and Sema4D in colorectal carcinoma tissues].
    Mu L; Wang J; Guo X; Zheng S; Shan K; Jing C; Li L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):388-92. PubMed ID: 24760652
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Pathogenesis of microsatellite-unstable colorectal cancer. Evaluation of new diagnostic and therapeutic options].
    Kloor M
    Pathologe; 2013 Nov; 34 Suppl 2():277-81. PubMed ID: 24196629
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
    Alexopoulou DK; Papadopoulos IN; Scorilas A
    Clin Biochem; 2013 Oct; 46(15):1453-61. PubMed ID: 23499583
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.